promiscuous drugs compared selective drugs promiscuity virtue abstract background word selectivity describes drug's ability affect cell population preference part current state art search therapeutic agents property selectivity mode action thought high degree desirability growing activity area research selectivity generally worthy property drug drug high selectivity dramatic effect single agent targeted molecular-driver involved pathogenesis disease chronic myeloid leukemia cml cml specific chromosomal abnormality philadelphia chromosome results single gene produces abnormal protein discussion burgeoning understanding cellular mechanisms control etiology pathogeneses diseases understanding enables motivates development drugs induce specific action selected cell population i e targeted treatment drugs target distinct molecular targets involved pathologic/pathogenetic processes signal-transduction pathways developed cases diseases involve multiple abnormalities disease dysfunctional protein out-of-balance likewise drug strongly target protein shares similar active domain proteins drug target pleiotropic cytokines proteins multi-physiological functions multiple normal cellular pathways simultaneously influenced long term experience drugs supposedly designed single target unavoidably involve functional effects uncovering fact molecular targeting medically flawless summary contend ideal drug efficacy based inhibition single target rebalancing proteins events contribute etiology pathogeneses progression diseases i e effect promiscuous drug ideally minimum drug concentration side effects minimized corollaries argument growing fervor researching selective drugs imprudent totality responses expensive screening techniques discover medically financially inefficient 
